Arcus Biosciences Inc.
RCUS | NYSE
$25.95
+$0.71 (+2.81%)
At close: Sep 21, 2026, 4:00 PM ET
$25.95
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:06 PM ET
Market Data
Market Cap $3.17B
Enterprise Value $2.68B
Beta 0.81
Average Volume 1.2M
Shares Outstanding (Diluted) 126.1M
Shares Change YoY 18.4%
Institutional Ownership 94.98%
Exchange NYSE
ISIN US03969F1093
Price Performance
Price Change 1M -15.0%
Price Change 3M -7.9%
Price Change 6M 20.9%
Price Change YTD 11.4%
Price Change 1Y 107.3%
Price Change 3Y 31.6%
Price Change 5Y -27.9%
1M CAGR (ann.) -10.9%
1Y CAGR (ann.) 109.8%
5Y CAGR (ann.) -4.9%
All-Time CAGR 4.8%
Valuation
PE Ratio -6.60
Forward PE N/A
PEG Ratio 0.31
Forward PEG 2.41
PS Ratio 27.90
Forward PS 69.80
PB Ratio 7.03
P/FCF Ratio -5.32
P/Adj. FCF Ratio -4.70
P/OCF Ratio -6.90
EV/Sales 22.87
EV/EBIT -6.24
EV/EBITDA -6.39
EV/FCF -4.37
Earnings Yield -15.1%
FCF Yield -18.8%
Adj. FCF Yield -21.3%
Financial Health
Net Cash $601M
Total Debt $114M
Cash & Short-Term Investments $702M
Total Assets $924M
Current Ratio 3.82
Quick Ratio 3.82
Debt / Equity Ratio 0.25
Debt / EBITDA -0.27
Debt / FCF -0.19
OCF / Debt -5.37
Interest Coverage -21.13
Altman Z-Score 0.88
Piotroski F-Score 0
Margins & Profitability
Gross Profit Margin 94.0%
Operating Profit Margin -415.4%
EBITDA Margin -358.1%
Net Profit Margin -386.3%
FCF Margin -523.9%
Adj. FCF Margin -594.0%
SBC / Revenue 53.9%
SBC Impact (per share) -13.4%
Returns
Return on Assets -48.9%
Return on Equity -88.0%
Return on Invested Capital -65.8%
Return on Capital Employed -66.9%
Return on Tangible Assets -48.9%
Historical Growth (CAGR)
Revenue CAGR 3Y -1.0%
Revenue CAGR 5Y 4.7%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -12.2%
EPS CAGR 5Y -32.3%
EPS CAGR 10Y N/A
FCF CAGR 3Y -42.5%
FCF CAGR 5Y -98.4%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 18
EPS Growth Next 3Y 23.0%
Revenue Growth Next 3Y 52.5%
Earnings Date Oct 26, 2026
EPS Estimate (next Q) -$0.94
EPS Growth Est (next Q) -26.0%
Revenue Est (next Q) $11.03M
Revenue Growth Est (next Q) -57.6%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $40
Price Target Upside 54.1%
Cash Flow
Operating Cash Flow $-612M
Free Cash Flow $-613M
Adj. Free Cash Flow $-695M
FCF Per Share -$3.77
OCF Per Share -$3.76
OCF/S Ratio -405.1%
Income Statement
Revenue $117M
Gross Profit $110M
Operating Income $-486M
EBITDA $-419M
Net Income $-452M
EPS (Diluted) -$3.93
Revenue / Employee $194.68K
Profit / Employee $-752.08K
Employees 601
Add to Watchlist
Select watchlists to add or remove RCUS